Chemical Dependence and Substance Use Disorders: Prevention and Treatment
Fulfills requirement: California pre-licensure for LCSWs, LPCCs, and MFTs. This course is also offered as part of a Pre-Licensing Savings Package. Note: For psychologists looking to fulfill CA pre-licensure requirements, the 15 hours of coursework in Chemical Dependency must be completed at an academic institution.
According to the most recent National Survey on Drug Use, approximately 16.8% of people ages 12 years or older have had a substance use disorder in the past year, including 27.9 million people with an alcohol use disorder and 28.2 million people with a drug use disorder. Although these statistics can be helpful in understanding the scope of the problem, they do not fully capture the impacts on individuals, families, institutions, and entire communities. Indeed, chemical dependence is a complex public health, mental health, and social issue.
Chemical dependence often is understood as a chronic, relapsing medical condition with long-term changes in brain reward pathways and stress regulation systems. Although there are various effective treatments (including psychotherapy, medications, and recovery support services), many people who need care receive it too late, receive inadequate treatment, or do not receive it at all. Many people struggle with chemical dependence for years without receiving professional help due to lack of access to services, financial barriers, stigma and fear of judgment, and lack of awareness about available treatments.
This intermediate-level course begins with the scope of the problem of chemical dependence from a public health perspective. It provides an overview of many of the more common substances that mental health professionals are likely to encounter in their work with clients across their lifespan. Content also addresses two additional layers of complexity – polysubstance use and comorbidity with other psychiatric disorders – and covers risk factors, prevention, and harm reduction. The second half of the course shifts to various topics in intervention. It identifies the mechanisms for behavior change with and without treatment and explores the relationship between stress and relapse. The course concludes with an in-depth exploration of the range of evidence-based assessments and treatments, including culturally responsive approaches.
Content consists of original written content, fourteen open-access journal articles, and two interviews with experts in the field of substance abuse treatment – Larry Fritzlan, a marriage and family therapist who works with families and Alan Marlatt, a psychologist who utilizes mindfulness skills. All content is available in audio and written formats.
Disclaimer: This course is purely educational and does not intend to serve as a license (or permission) to mental health professionals to prescribe or practice any of the approaches discussed in this course unless they fall within the scope of practice of your profession. Check with your licensing board about the scope of practice of your profession to make sure you practice within that scope. It also does not serve as permission to title yourself in any specific way.
Educational Objectives
-
Describe the scope of the problem of chemical dependence from a public health perspective.
-
Explain the various substances in terms of their methods of administration, short-term and long-term effects on the body, and withdrawal symptoms.
-
Discuss how polysubstance use and comorbid psychiatric diagnoses adds layers of complexity to assessment and treatment.
-
Identify risk factors, prevention approaches, and harm reduction among adolescents and young adults.
-
Describe evidence-based assessment of substance use disorders.
-
Discuss the range of contemporary psychological and pharmaceutical treatment options available for substance use disorders.
-
Discuss the importance of culturally responsive approaches to treatment of racial and ethnic minorities.
Syllabus
- Summary of 2024 National Survey on Drug Use and Health (NSDUH) results
- Alcohol and other commonly abused substances
- Short- and long-term effects on body
- Effects on pregnancy
- Common withdrawal symptoms
- Public health approach versus law enforcement approach to substance use disorders
- Polysubstance use
- Substances involved
- Timing
- Intent of use
- Comorbidity with psychiatric disorders
- Prevalence and characteristics of dual diagnoses
- Complex nature of comorbidity
- Role of integrated care
- Addressing comorbidity in alcohol use disorders and anxiety/depression
- Addressing comorbidity in stimulant use disorders and ADHD
- Individual, familial, environmental, and societal risk factors
- High-impact prevention strategies
- Incorporating harm reduction into practice
- Behavior change
- Defining substance use disorder, remission, and recovery
- Identifying mechanisms for behavior change
- Treatment-specific mechanisms
- Common mechanisms
- Neurobiological, neurocognitive, and physiological factors
- Role of stress in risk, relapse, and treatment outcomes
- Multilevel adaptive stress response
- Factors affecting stress response, learning and motivation
- Stress-drug use cycle and treatment failure
- Targeting stress pathophysiology in prevention, intervention, and treatment
- Evidence-based assessment of substance use disorder
- Assessment targets
- Assessment instruments
- Assessment processes
- Screening and management of substance abuse in older adults
- Common general questions about treatment approaches
- Drug addiction treatment in the United States
- Types of treatment programs
- Treating criminal justice-involved drug abusers and addicted individuals
- Evidence-based psychological approaches to drug addiction treatment
- Behavioral therapies
- Behavioral therapies primarily for adolescents
- Family intervention treatments
- Mindfulness approaches
- New strategies for medications to treat substance use disorders
- Challenges in medication development
- Therapeutic potential of psychedelics in treating substance use disorders
- Culturally-responsive substance use treatment
- Cultural adaptations of evidence-based treatment
- Implementing novel strategies
- Gaps and future directions
